WWW.ISPESINGAPORE.ORG
ISPE Singapore Affiliate Conference and Exhibition 2020 will be a virtual event
With immersive virtual broadcasting and networking, this event will be accessibleto pharma industry stakeholders globally.
600+PARTICIPANTS
65+SPEAKERS
25+COUNTRIES
3DAYS
CONFERENCE AND EXHIBITIONTechnology Innovations, Improving Healthcare
9 - 11 December 2020 I Virtual Conference
QUALITY & COMPLIANCE
COVID-19 MARKET SCENARIOS
INDUSTRY-REGULATOR
COLLABORATION
DATA INTEGRITY & GAMP
TECHNOLOGY DEVELOPMENT IN MANUFACTURING
INNOVATIONS IN DIGITAL PHARMA
REGULATORY AND COMPLIANCE
POST CONFERENCE:
BEST PRACTICES & TECHNOLOGY
SYMPOSIUMTOPICS COVERED IN 2020
DELIVERED DIGITALLY
Organised by:
WWW.ISPESINGAPORE.ORG
CONFERENCE AND EXHIBITION
AGENDA AT A GLANCE:
ABOUT THE CONFERENCEISPE Singapore Affiliate Conference and Exhibition 2020 will be a fully virtual event. You will experience a high-quality live stream of the event, that promises all the content as well as virtual networking options. Join and interact in live discussions, catch up on sessions you missed or watch again after the event.
With a record 1000+ participants, the ISPE Singapore Affiliate Conference and Exhibition broke new ground in 2019. We saw a strong presence of Pharma and Manufacturers, supported in equal measure my Regulators, EPCM, and various other stakeholders and service providers.
TRACK 1 TRACK 2 TRACK 1 TRACK 2
#INTERACTIVE LIVE CHATS AND DISCUSSIONS
TECHNICAL DIGITAL THEATERS
PRE EVENT ROUNDTABLE DISCUSSIONS
WORKSHOPS
REGULATOR KEYNOTE:PIC/s Inspection Reliance and Desktop Inspections
PLENARY PANEL DISCUSSION:Pandemic Crisis Response: Ensuring the Cure Isn’t Worse
than the Disease
KEYNOTE ADDRESS:Embracing the Digital Pharma Factory of Tomorrow
PANEL DISCUSSION:Reaching Digital Maturity
through Pharma 4.0
Regulatory & ComplianceTechnology Developments
in Manufacturing
Regulatory & Compliance Innovations in Digital Pharma Regulatory & Compliance Technology Developments
in Manufacturing
Data Integrity Technology Developments
in Manufacturing
PRE-CONFERENCE ACTIVITIES
DAY 1 9TH DEC 2020
DAY 2 10TH DEC 2020
DAY 3 11TH DEC 2020
TRACK 1 TRACK 2JOINT OPENING PLENARY SESSIONS JOINT PLENARY SESSIONS
Virtual Conference Highlights:Gain access to unique live content across three days along with quality networking and matchmaking opportunities!
60+ VIRTUAL LIVESTREAM SESSIONS: Hear from global market experts and plan your participation with a virtual agenda, customisable to opt into panels and presentations across the three days.
QUALITY NETWORKING:With intent based and AI powered virtual matchmaking, you will meet quality leads over 1:1 meetings to make meaningful connections.
ON DEMAND CONTENT:We will provide full access for you to view our quality content on demand for up to three months after the event so you don’t miss out on any session.
VIRTUAL EXHIBITION:A virtual showcase of players in the industry for you to view product demos, network and take your business to the next level.
WWW.ISPESINGAPORE.ORG
STELLAR LINE-UP OF GLOBAL PHARMA MANUFACTURERS AND EXPERTS
SPONSORS AND EXHIBITORSKey SponsorAssociate
SponsorSponsor Track Sponsor Exhibitors
David Churchward Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector) MHRA, UK
Chong Hock Sia Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group Health Sciences Authority, Singapore
Sook Peng Chua ASEAN Regulatory and Quality Compliance Director Johnson and Johnson (J&J), Singapore
Anchalee Anuchitanukul Head of Compliance, Pharmaceuticals, Country Compliance Head Novartis, Thailand
Pakhi Rusia Director of Global Regulatory Affairs GSK, Singapore
Ewelina Markuszewska Quality Control Expert DaviPharm (Adamed Group), Vietnam
Lam Quang Nhat Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive Daiichi Sankyo Co., Ltd., Vietnam
Hazem Eleskandarani Project Director, Engineering & Property Services Johnson & Johnson, United States
Dr. Faseeh Abdus Salam Production Head FAAS Pharmaceutical Pte. Ltd., Pakistan
Dasarathi KKC Head of Regulatory Affairs (API) Aurobindo Pharma, India
Roger Harty Director of EMEA & APAC AstraZeneca, Belgium
Samme Wang Head of Engineering and Technology Asia Bayer, Singapore
James Wu Chief IT Officer Roche, Taiwan
Rajnish Narula Director Business Excellence Pfizer, Singapore
Rajesh Thempadiyil Business Process Excellence & CoE Lead Dr. Reddy’s Laboratories Ltd., India
Ahmed Abdel Rahman Bashtar Regional QA Compliance Head Julphar, United Arab Emirates
Meidi Fransisca Siregar IT Manufacturing Lead PT Bayer Indonesia
Ewan Dowie Head of Production Ego Pharmaceuticals, Australia
Raneeth Reghu Head of Procurement Biocon Biologics, Malaysia
Minh Tran Chief Operating Officer Stelis Biopharma, India
Dr. Anthony Deodaunia William Senior Manager Technical Operations- API Manufacturing AbbVie, Singapore
Shailendra Singh Bhadoria Head- Manufacturing and Sciences Oncogen Pharma, Malaysia
Md. Zakar Executive Director, Plant Operations NIPRO JMI Pharma Ltd., Bangladesh
Ahmad Fikri Hasim Head of Production Ain Medicare Sdn Bhd, Malaysia
Taufik Muhammad Engineering Compliance Expert Novartis, Singapore
WWW.ISPESINGAPORE.ORG
WEDNESDAY, 9 DECEMBER 2020: DAY 1
14:40 Online Networking & Stretch Break
18:30 End of Virtual Conference Day 1
17:40 End of Virtual Conference Day 1
13:00 Welcome RemarksShanshan Liu, President, ISPE Singapore Affiliate
13:10 Opening AddressFran Zipp, International Board Chair, ISPE, & Chief Executive Officer, Lachman Consultant Services, United States
13:20 The Impact of COVID-19 on Government Investments & Partnerships in Healthcare InnovationSenior Representative from Singapore’s Economic Development Board
13:40 ASEAN MRA Update and International Reliance Programs• Future ASEAN developments on pharmaceutical inspections • Singapore’s partnerships in MRAs and reliance in pharmaceutical inspection and regulation Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore
14:10 Update on ICH-Q13 Dr. Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, Japan
JOINT OPENING PLENARY SESSIONS
REGULATORY & COMPLIANCE:Chairperson: Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPE
INNOVATIONS IN DIGITAL PHARMA
16:00 REGULATOR KEYNOTE: PIC/s Inspection Reliance and Desktop Inspections Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland
16:30 PANEL DISCUSSION: Industry-Regulator Collaboration • Training • Regulatory document reviews • Identification of emerging problems
Moderator: Vasiliki (Vee) Revithi, Ex-Head, GMDP Inspectorate, EOF Medicines Agency of Greece
Panellists: Sook Peng Chua, ASEAN Regulatory and Quality Compliance Director, Johnson and Johnson (J&J), Singapore Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore Dr. Georg Singewald, VP, Head of Global Quality Control, Genentech, United States Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland
17:15 Brexit UpdateDavid Churchward, Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), MHRA, UK
17:45 PLENARY PANEL DISCUSSION: Pandemic Crisis Response: Ensuring the Cure Isn’t Worse than the Disease • Drug shortages • Regulating for expedited trials and approvals • Balancing ethical processes vs speed to
market • Maintaining risk and compliance while
scaling agile • COVID 19: Lessons learned in effective global
co-operation in times of crisis
Moderator: Robert Tribe, Asia-Pacific Regulatory Affairs Advisor, ISPE Panellists: David Churchward, Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP Inspector), MHRA, UK Dr Yoshihiro Matsuda, Senior Scientist (for Quality) PMDA, & Regulatory Chair, ICH-Q13, Japan Anne Hayes, Inspection Manager, Health Products Regulatory Authority, Chairman, Pharmaceutical Inspection Co-operation Scheme (PIC/S), Ireland
15:10 Significance of Digitalisation in Operations and Usage of Pharma 4.0 for Accelerating the Same • What we learned from lock down conditions • Business Continuity Plan during COVID 19 • Change in operations strategy after COVID19 Rajesh Thempadiyil, Business Process Excellence & CoE Lead, Dr. Reddy’s Laboratories Ltd., India”
15:40 Technologies Reshaping the Future of the Pharma Industry • History of the tech revolution and its link to
the pharma industry • Remaining barriers to tackle • Top technological approaches to use in
pharma • Examples of newly-applied tech in therapies
like personalised medicine Ahmed Abdel Rahman Bashtar, Regional QA Compliance Head, Julphar, United Arab Emirates
16:10 Technology Innovation for the Future James Wu, Chief IT Officer, Roche, Taiwan
16:40 State of IT Security in Pharma Manufacturing • Background of pharma manufacturing IT
security • Pharma industry risks and treats • Industry trends and their impact on security • Gaps analyses and best practices
Meidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia
17:10 Flexible and Smart Production of Tomorrow’s Medicines • The healthcare sector is facing tremendous
changes• Novel Cell & Gene Therapies such as CAR-T
conquer the market• Pharmaceutic production methods change
radically• Flexible plants for prudent CAPEX decisionsDr. Stefan Kappeler, Technology Manager Life Sciences, Exyte, Switzerland
WWW.ISPESINGAPORE.ORG
THURSDAY, 10 DECEMBER 2020: DAY 2
17:15 KEYNOTE ADDRESS: Embracing the Digital Pharma Factory of Tomorrow • AstraZeneca’s current digital factories initiative strategy• How the factories of the future will bring about change• How to successfully imbed this change in the organizational cultureRoger Harty, Director of EMEA & APAC, AstraZeneca, Belgium
17:45 PANEL DISCUSSION: Reaching Digital Maturity through Pharma 4.0 • Applying Big Data, information systems and digital tech in pharma manufacturing• Life cycle management for organisation and process• Major issues and success factors facing digital transformation• Communication and decision making driving cultural change
Moderator: Pierre Winnepenninckx, Conference Chair, ISPE Singapore Affiliate & Chief Executive Officer, No Deviation Pte. Ltd.
Panellists: Roger Harty, Director of EMEA & APAC, AstraZeneca, Belgium James Wu, Chief IT Officer, Roche, TaiwanSamme Wang, Head of Engineering and Technology Asia, Bayer, Singapore Rajnish Narula, Director Business Excellence, Pfizer, Singapore “
JOINT CLOSING PLENARY SESSIONS
REGULATORY & COMPLIANCEChairperson: Fran Zipp, International Board Chair, ISPE, & Chief Executive Officer,
Lachman Consultant Services, United StatesTECHNOLOGY DEVELOPMENTS IN MANUFACTURING
13:00 Compliance Monitoring: A Health Check-Up Tool and its Importance • What is compliance monitoring and why is it
crucial?• Challenges & techniques to improve
monitoring to anticipate and mitigatecompliance risk
Anchalee Anuchitanukul, Country Head Ethics, Risk and Compliance, Novartis, Thailand
13:30 Quality by Design during Product Development & Beyond Pakhi Rusia, Director of Global Regulatory Affairs, GSK, Singapore
14:00 Transitioning of EU GMP and Adapting Entry into Emerging Markets • Some regulatory characteristics of the
Vietnamese Drug Administration (DAV)• How harmonized are the different
international standards on drug production(ASEAN GMP, WHO GMP, EU GMP)? *Compliance and data integrity challenges inVietnam, and lessons learnt
Ewelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), Vietnam
14:30 Managing Regulatory Compliance in Vietnamese Pharma Market • Impact of the new Decree 155 on regulatory
compliance• Considerations to align your Big Pharma
regulatory strategy to the local market• Inspection Readiness: what to expect and
how to prepareLam Quang Nhat, Quality Assurance, Pharmacovigilance, Regulatory Affairs Executive, Daiichi Sankyo Co. Ltd., Vietnam
15:00 Myanmar Pharma Industry View on ASEAN GMP • Updates on ASEAN MRA on GMP• Compliance with ASEAN GMP• Meeting data integrity requirements in
MyanmarChandrakant Bhandare, Head of Quality, Zydus Cadila Myanmar
15:30 Building the External Supplier Relationship: Ensuring a Safe, Compliant and Productive Supply Chain• Compliance expectations for both the MAH
Holder and the CMO/Lab• Quality Agreements – what they need to
include• Supply Agreements – how they can aid the
relationship• MAH oversight and staffing needs – many
companies understaffBeth Haas, Principal Consultant / Senior Project Manager, CAI, USA
16:00 ICH Q12 Case Studies:
Case Study: Using Established Conditions to Facilitate Post-Approval Regulatory ChangesConnie Langer, Regulatory Strategist, Pfizer, United States
AstraZeneca’s Experience with the FDA Pilot & Preparation for Subsequent Implementation in Other RegionsFrank Montogomery, Global Head, Regulatory CMC, AstraZeneca, United Kingdom
The Journey Towards Regulatory Convergence in Product Life Cycle Management: ICH Q12 and BeyondNina Cauchon, Director, Amgen, United States
13:00 Leadership, Lean Manufacturing and Pharma 4.0 Ewan Dowie, Head of Production, Ego Pharmaceuticals, Australia
13:30 Pharmaceutical Water Systems• Cost effective WFI generation by Vapor
Compression Distillation• Vapor Compression Vs Traditional Multi
Effect DistillationDr. Louis Hon, Technical Sales Manager, MECO Water Purification Pte Ltd, Singapore
14:00 The Role of Design of Experiments in the Product Lifecycle Management • Product Lifecycle management fundamentals
and stages of product realization• Key elements of quality by design (QbD)• Design of Experiment as a powerful
technique of QbD & Process Optimization• Practical considerations for implementing
compression profiling & Design ofExperiment for Oral Solid Dosage Forms
Alfonso Quiros, New Product Introduction & Technical Head, Site Leadership Team Kuala Lumpur, CHSC Asia Pacific, GSK, Malaysia
14:30 Re-thinking Business Resiliency in Life Sciences 4.0Cyber-attacks or the threat of disruption to production are happening more frequently than ever. Business Agility has been challenged under such circumstances and it’s critical to put in place resiliency frameworks/technologies to recover business service, especially where companies strive to avoid a disruption in their supply to the market.
Joint Presentation:Claire Tran, Project Manager, Zenith, SingaporeLay Peng Tan, IT Manager, AbbVie Singapore Manufacturing
15:00 High Containment using Single Use Systems for HPAPI Manufacturing• Containment examples for reactor charging,
centrifuge off loading, dryer charging /discharging, and conical milling processes
Scott Patterson, Vice President Pharma / BioPharma Technical Support, ILC Dover, USA
15:30 Improving Energy Efficiency in Pharmaceutical Manufacturing Taufik Muhammad, Engineering Compliance Expert, Novartis, Singapore
16:00 Trends and Technology in Modern Aseptic Processing • Current trends and challenges in final fill• Regulatory overview• Key considerations for contained
manufacturing to ensure patient safetyAshok Kumar, Single Use Bioprocessing Regional Manager - India and Southeast Asia, Merck Life Science, India
18:30 End of Virtual Conference Day 2
“The ISPE conference is an excellent way to get energised to deliver value to my organization. I f eel confident in the implementation of concepts I learnt here”.Catherine Le Denmat, Associate Engineer, MSD
16:45 Online Networking & Stretch Break
17:00 Online Networking & Stretch Break
16:30 Considerations for an Industry 4.0Vaccine National Platform • State of vaccine self-sufficiency & impact of
COVID-19 pandemic• Snapshot of latest innovations in
manufacturing technology for vaccinesindustry 4.0
• Considerations for different expressionplatforms for producing vaccine drugsubstances & manufacturing technologies
• New drug delivery systems & formatsexplored
Xiangliang Lin, Founder,President & CEO, Esco Aster, Malaysia
WWW.ISPESINGAPORE.ORG
FRIDAY, 11 DECEMBER 2020: DAY 3
15:15 Online Networking & Stretch Break
15:15 Online Networking & Stretch Break
17:30 End of Virtual Conference Day 3 18:15 End of Virtual Conference Day 3
REGULATORY & COMPLIANCE: TECHNOLOGY DEVELOPMENTS IN MANUFACTURING
13:00 PANEL DISCUSSION: Regulatory Compliance in Emerging Markets Moderator: Alfonsus Karli, APAC GCMC Advisory Office Director, Pfizer Pte Ltd & ISPE Singapore Affiliate Vice Chair, Regulatory Affairs Panellists: Anchalee Anuchitanukul, Country Head Ethics, Risk and Compliance, Novartis, Thailand Chandrakant Bhandare, Head of Quality, Zydus Cadila Myanmar Ewelina Markuszewska, Quality Control Expert, DaviPharm (Adamed Group), Vietnam Chong Hock Sia, Senior Consultant, Audit & Licensing, Director, Quality Assurance, Health Products Regulation Group, Health Sciences Authority, Singapore
13:45 Implementing and Complying with International cGMPs in Pakistan’s Pharma Industry• Overview of regulatory framework and
national pharma manufacturing industry inPakistan
• Major challenges confronting the industry• Importance of cGMP to combat quality issues
in pharma: Identity, quality, strength & purityof drug
• Proper design, monitoring and control onmanufacturing process and facilities
Dr. Faseeh Abdus Salam, Production Head, FAAS Pharmaceutical Pte. Ltd., Pakistan
14:15 Changing Regulatory Landscape and Current Challenges for the API Industry• Areas of regulatory changes from past years
to recent• New trends in regulatory enforcement in life
sciences• New requirements to reduce audit
compliance risk in the current scenario• Regulatory compliance through real data
managementDasarathi KKC, Head of Regulatory Affairs (API), Aurobindo Pharma, India
14:45 Understanding Regulatory Requirement on Cleaning and Disinfection• Cleaning and Disinfection. Debunking the
myth.• Regulatory expectations – Draft Annex 1, FDA
and PIC/S• How to demonstrate compliance to
inspectorsRichard Chai, Technical Service Manager, STERIS Corporation, Singapore
13:00 Sourcing Challenges and Imperatives in the Biologics Space • Current state of end-end manufacturing
processes for biologics• Challenges specific to manufacturing
biologics• Best practices in vendor managementRaneeth Reghu, Head of Procurement, Biocon Biologics, Malaysia
13:30 CASE STUDY: Lean CapEx Project Delivery to Support Patients in Asia-Pacific • Importance of capital-expenditure
management in pharma• How does lean help to maximize CapEx
benefits and patient-centricity?• Project Management team:
• Project methodology• Externalisation• Talent development
Samme Wang, Head of Engineering and Technology Asia, Bayer, Singapore
14:00 Isolators for Pharmaceutical Manufacturing Shailendra Singh Bhadoria, Head- Manufacturing and Sciences, Oncogen Pharma (Malaysia)
14:30 CLEANING VALIDATION & VERIFICATION CASE STUDY: • From Initial Tech Transfer from API to
Commercial ManufacturingDr. Anthony Deodaunia William, Senior Manager Technical Operations- API Manufacturing, AbbVie, Singapore
DATA INTEGRITY
15:30 Data Integrity Compliance and Key to Reduce Data Integrity Violation TrendsShantha Kumara, Quality Assurance Manager, Strides Pharma, Singapore
16:00 Statistical Techniques for Product Quality Improvement & Monitoring• Importance of applying statistical thinking to
quality improvement• Overview of practical and simply statistical
methods used for quality improvement• Practical and statistical considerations when
choosing a statistical method to useMd. Zakar, Executive Director, Plant Operations, NIPRO JMI Pharma Ltd., Bangladesh
16:30 Developing a Robust Quality System to Assure Data Integrity• Regulatory trends and guidance in
Philippines’ pharma industry• How data integrity and process monitoring
are critical to each other for regulatorycompliance
• Link between data integrity and qualityculture
• Remaining pain-points in data integrityCloyd Lambojon, Supervisor Production / Site Data Integrity Lead, GSK, Philippines
17:00 Merging Laboratory and Manufacturing Data• This presentation will give an introduction
to digital sensor technologies and resultingbenefits and capabilities.
• The merging of laboratory and manufacturingdata is shown based on a practical example.
Dr Michael Weiss, Product Management, Endress+Hauser Conducta GmbH+Co. KG, Germany
15:30 Key Considerations for Successful Implementation of Single Use Systems in Final Filling of Drug Products Minh Tran, Chief Operating Officer, Stelis Biopharma, India
16:00 Time for Integrating Excellence Models in Pharma • Visual management• Data-driven performance management• Systematic process for generating and
implementing continuous improvementsRajnish Narula, Director Business Excellence, Pfizer, Singapore
16:30 Basic Considerations and Implementation of Track and Trace in Pharma Manufacturing • Regulatory environment and global
requirements • Benefits of track and trace system to the
pharma industry• Key elements of a successful track and trace
system• Challenges in implementing track and trace
technologyAhmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia
17:00 Planning & Executing a Successful Project• Definition of a successful project• Elements of a successful project
• Project Charter• Team Structure• Project Planning• Execution Stage• Project Close Out
• Project Management challenges in thepharmaceutical industry
Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USA
17:30 PANEL DISCUSSION: Lean Manufacturing Operations – Achieving More with Less • Strategies to achieving pharma operational
excellence • Best practices to optimise flexible and agile
production`• Reducing waste, maximising productivityModerator: Hazem Eleskandarani, Project Director, Engineering & Property Services, Johnson & Johnson, USA
Panellists: Minh Tran, Chief Operating Officer, Stelis Biopharma, India Dr. Anthony Deodaunia William, Senior Manager Technical Operations - API Manufacturing, AbbVie, Singapore Meidi Fransisca Siregar, IT Manufacturing Lead, PT Bayer Indonesia Ahmad Fikri Hasim, Head of Production, Ain Medicare Sdn Bhd, Malaysia
WWW.ISPESINGAPORE.ORG
Dear industry colleagues,
COVID-19 has shaken up industry operations as pharmaceutical manufacturing leaders are rallying to accelerate processes to bring about key medicines across borders. As the industry transforms at rigorous speed; learning developments for technical and commercial best practices are being continually refined in all aspects of manufacturing.
ISPE Singapore Affiliate’s annual conference is pleased to once again offer you a learning and networking opportunity like no other in Singapore. The 2020 edition will be fully virtual.
You will experience a high-quality live stream of presentations, dedicated discussions, virtual networking options during the event, and on-demand content is available up to 3 months after the conference.
2019 attracted a record 1000+ participants, the ISPE Singapore Conference and Exhibition broke new ground in 2019. We saw a strong presence of Pharma and Manufacturers, supported in an equal measure by Regulators, EPCM, and various other stakeholders and service providers. We hope to see more participation as a hybrid conference format opens more opportunities for the global community to log on and learn.
As above, industry support by itself is our testament to the quality, and we promise an even better, newer, and value-packed event experience for your benefit.
Do make the time to attend with your teams. I am confident it will generate great learning value for your organisation.
I look forward to meeting you in December, online.
With regards,
Pierre WinnepenninckxChairISPE Singapore Conference 2020
WWW.ISPESINGAPORE.ORG
10,000+Contacts
Email Outreach
75,791LinkedIn
Impressions
12,438Unique Website Visitors from 112
Countries
MAKE AN INVESTMENT INTO YOUR COMPANY’S FUTURE WITH OUR DIGITAL SPONSORSHIP AND EXHIBITION PACKAGES
To discuss opportunities for raising your brand profile Contact: Yvonne Leong
T: +65 6508 2489 E: [email protected]
Sponsorship OpportunitiesSponsoring a part of the ISPE Singapore Conference & Exhibition allows companies to target key decision makers in the international pharma manufacturing industry.
• Create company exposure
• Strengthen your brand position
• Reinforce relationships
• Raise your profile before, during and after the event
25+Trade Media and Industry Association
Partners
THOUGHT LEADERSHIP
Offer keynotes and educational sessions to you audience through
live webinars or pre-recorded video broadcast with automated reminders, Q & A sessions and polls to keep your
attendees engaged.
INFORMA DATA+
Unique option for increased lead generation through retargeting of our global proprietary database in social
media
POWERFUL DIGITAL MATCHMAKING
Build valuable relationships with our intelligent matchmaking tool, live chat
and integrated 1:1 video calls.
VIRTUAL BOOTHS
Online spaces with your brand identity, showcase your product demos, live
chat with audiences. Manage your own logo, description video, collateral, staff
profiles and more.
FOCUSED METRICS
Measurable exposure and trackable meetings generate great ROI. Booth
views, meeting requests, engagement rates – you’ll have all the data you need
ACCELERATED BRAND EXPOSURE
Gain prominence with focused digital theatres in the lead up, main
conference days, and up to 3 months after the event with our on-demand
content modules
OUR MARKETING OUTREACH!
P46412
Special Corporate Rate: Register 50 delegates: SGD $8895
ISPE Member – Please provide ISPE membership ID during registration
FEE PER DELEGATEEarly Bird RateRegister & pay before 31 October 2020
Normal RateRegister & pay after 31 October 2020
Group Rate(per person, 3 or more delegates)
Live Online Experience (Per delegate) $600 $700 $600
Non ISPE Member BECOME A MEMBER
FEE PER DELEGATE (SGD)Early Bird RateRegister & pay before 31 October 2020
Normal RateRegister & pay after 31 October 2020
Group Rate(per person, 3 or more delegates)
Live Online Experience (Per delegate) $750 $850 $750
Government, Academic & Emerging Markets Rate
Live Online Experience (Per delegate) $300
Special Group Rates for Pharma Companies
Live Online Experience (Per delegate) $500
REGISTRATION
3 EASY WAYS TO REGISTERContact Miki Kong+65 6508 2477
Registration Enquiry [email protected]
Websitewww.ispesingapore.org
1. For cancellation/substitution terms & conditions, please visit: https://www.informaconnect.com.sg/terms/
2. Informa Connect is a trading name of IBC Asia Pte Ltd Informa Connect
*ISPE Singapore Affiliate Conference And Exhibition 2021 will be back to a physical event, please stay tuned for more 2021 updates
9-11 December 2020Virtual Conference
CONFERENCE AND EXHIBITION
Top Related